158 related articles for article (PubMed ID: 26745766)
81. Novel imidazo[1,2-a]pyridine derivatives as potent ATX allosteric inhibitors: Design, synthesis and promising in vivo anti-fibrotic efficacy in mice lung model.
Lei H; Li Z; Li T; Wu H; Yang J; Yang X; Yang Y; Jiang N; Zhai X
Bioorg Chem; 2022 Mar; 120():105590. PubMed ID: 34998121
[TBL] [Abstract][Full Text] [Related]
82. Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.
Keune WJ; Potjewyd F; Heidebrecht T; Salgado-Polo F; Macdonald SJ; Chelvarajan L; Abdel Latif A; Soman S; Morris AJ; Watson AJ; Jamieson C; Perrakis A
J Med Chem; 2017 Mar; 60(5):2006-2017. PubMed ID: 28165241
[TBL] [Abstract][Full Text] [Related]
83. Discovery of non-boronic acid Arginase 1 inhibitors through virtual screening and biophysical methods.
Gathiaka S; Palte RL; So SS; Chai X; Richard Miller J; Kuvelkar R; Wen X; Cifelli S; Kreamer A; Liaw A; McLaren DG; Fischer C
Bioorg Med Chem Lett; 2023 Mar; 84():129193. PubMed ID: 36822300
[TBL] [Abstract][Full Text] [Related]
84. Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.
Jones SB; Pfeifer LA; Bleisch TJ; Beauchamp TJ; Durbin JD; Klimkowski VJ; Hughes NE; Rito CJ; Dao Y; Gruber JM; Bui H; Chambers MG; Chandrasekhar S; Lin C; McCann DJ; Mudra DR; Oskins JL; Swearingen CA; Thirunavukkarasu K; Norman BH
ACS Med Chem Lett; 2016 Sep; 7(9):857-61. PubMed ID: 27660691
[TBL] [Abstract][Full Text] [Related]
85. Novel Pyridazines as Autotaxin Inhibitors for Treating Inflammatory Airway or Fibrotic Diseases.
Sabnis RW
ACS Med Chem Lett; 2021 Apr; 12(4):528-529. PubMed ID: 33859788
[No Abstract] [Full Text] [Related]
86. Novel Pyridazines as Autotaxin Inhibitors for Treating Inflammatory Airway or Fibrotic Diseases.
Sabnis RW
ACS Med Chem Lett; 2021 Jul; 12(7):1067-1068. PubMed ID: 34267872
[No Abstract] [Full Text] [Related]
87. Autotaxin Inhibitors May Treat Pain and Osteoarthritis.
Abdel-Magid AF
ACS Med Chem Lett; 2014 Oct; 5(10):1072-3. PubMed ID: 26677406
[No Abstract] [Full Text] [Related]
88. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
89. Enteroendocrine cells are a potential source of serum autotaxin in men.
Bolier R; Tolenaars D; Kremer AE; Saris J; Parés A; Verheij J; Bosma PJ; Beuers U; Oude Elferink RPJ
Biochim Biophys Acta; 2016 Apr; 1862(4):696-704. PubMed ID: 26775031
[TBL] [Abstract][Full Text] [Related]
90. Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis.
Bain G; Shannon KE; Huang F; Darlington J; Goulet L; Prodanovich P; Ma GL; Santini AM; Stein AJ; Lonergan D; King CD; Calderon I; Lai A; Hutchinson JH; Evans JF
J Pharmacol Exp Ther; 2017 Jan; 360(1):1-13. PubMed ID: 27754931
[TBL] [Abstract][Full Text] [Related]
91. Autotaxin inhibitors: a patent review (2012-2016).
Nikolaou A; Kokotou MG; Limnios D; Psarra A; Kokotos G
Expert Opin Ther Pat; 2017 Jul; 27(7):815-829. PubMed ID: 28447479
[TBL] [Abstract][Full Text] [Related]
92. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.
Ackerman SJ; Park GY; Christman JW; Nyenhuis S; Berdyshev E; Natarajan V
Biomark Med; 2016; 10(2):123-35. PubMed ID: 26808693
[TBL] [Abstract][Full Text] [Related]
93. Autotaxin-LPA receptor axis in the pathogenesis of lung diseases.
Chu X; Wei X; Lu S; He P
Int J Clin Exp Med; 2015; 8(10):17117-22. PubMed ID: 26770305
[TBL] [Abstract][Full Text] [Related]
94. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis.
Desroy N; Housseman C; Bock X; Joncour A; Bienvenu N; Cherel L; Labeguere V; Rondet E; Peixoto C; Grassot JM; Picolet O; Annoot D; Triballeau N; Monjardet A; Wakselman E; Roncoroni V; Le Tallec S; Blanque R; Cottereaux C; Vandervoort N; Christophe T; Mollat P; Lamers M; Auberval M; Hrvacic B; Ralic J; Oste L; van der Aar E; Brys R; Heckmann B
J Med Chem; 2017 May; 60(9):3580-3590. PubMed ID: 28414242
[TBL] [Abstract][Full Text] [Related]
95. Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors.
Balupuri A; Lee DY; Lee MH; Chae S; Jung E; Kim Y; Ryu J; Kang NS
Bioorg Med Chem Lett; 2017 Sep; 27(17):4156-4164. PubMed ID: 28743508
[TBL] [Abstract][Full Text] [Related]
96. Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
Joncour A; Desroy N; Housseman C; Bock X; Bienvenu N; Cherel L; Labeguere V; Peixoto C; Annoot D; Lepissier L; Heiermann J; Hengeveld WJ; Pilzak G; Monjardet A; Wakselman E; Roncoroni V; Le Tallec S; Galien R; David C; Vandervoort N; Christophe T; Conrath K; Jans M; Wohlkonig A; Soror S; Steyaert J; Touitou R; Fleury D; Vercheval L; Mollat P; Triballeau N; van der Aar E; Brys R; Heckmann B
J Med Chem; 2017 Sep; 60(17):7371-7392. PubMed ID: 28731719
[TBL] [Abstract][Full Text] [Related]
97. Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System.
Eymery MC; Boumendjel A; McCarthy AA; Hausmann J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542186
[TBL] [Abstract][Full Text] [Related]
98. Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity.
Collie GW; Clark MA; Keefe AD; Madin A; Read JA; Rivers EL; Zhang Y
J Med Chem; 2024 Jan; 67(2):864-884. PubMed ID: 38197367
[TBL] [Abstract][Full Text] [Related]
99. Structure-Based Design of a Novel Class of Autotaxin Inhibitors Based on Endogenous Allosteric Modulators.
Clark JM; Salgado-Polo F; Macdonald SJF; Barrett TN; Perrakis A; Jamieson C
J Med Chem; 2022 Apr; 65(8):6338-6351. PubMed ID: 35440138
[TBL] [Abstract][Full Text] [Related]
100. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
